| BIOX |
Bioceres Crop Solutions Corp. |
90%
|
Reciprocal relationship from BIOX graph: In June 2024, we supplied Moolec Science SA ("Moolec"), one of our then affiliates, with an amount of HB4 soy equivalent to US$6.6 million |
| VALORASOY-FOOD-INGREDIENTS |
VALORASOY-FOOD-INGREDIENTS |
90%
|
ValoraSoy Food Ingredients specializes in the production of textured soy proteins and has a long track record of providing high-quality products and customized solutions to clients in more than 15 co… |
| BG |
Bunge Global SA |
72%
|
ethods significantly more efficient and productive. Recent Developments Collaboration Agreement with Bunge On August 6, 2024, Moolec Science Limited SE, our Argentine branch, entered into a collabora… |
| BG |
Bunge Global SA |
72%
|
Reciprocal relationship from BG graph: Reciprocal relationship from MLEC graph: ethods significantly more efficient and productive. Recent Developments Collaboration Agreement with Bunge On August 6,… |
| BIOX |
Bioceres Crop Solutions Corp. |
72%
|
Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Note issued to Bioceres Crop Solutions Corp .” We are developing a customer base for our fermentation and molec… |
| RKDA |
Arcadia Biosciences, Inc. |
72%
|
r activities that may be necessary to generate revenue and increase profitability. 11 We may face difficulties implementing our inorganic growth strategy, including not identifying suitable targets a… |
| RKDA |
Arcadia Biosciences, Inc. |
72%
|
Reciprocal relationship from RKDA graph: Reciprocal relationship from MLEC graph: Reciprocal relationship from RKDA graph: Reciprocal relationship from MLEC graph: r activities that may be necessary … |
| AG-BIOMOLECULES-LLC |
AG-BIOMOLECULES-LLC |
62%
|
Item 3. Key Information—D. Risk Factors—Risks Related to our Business and Operations—If our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein… |
| AGIDEA-USA-LLC |
AGIDEA-USA-LLC |
62%
|
Item 3. Key Information—D. Risk Factors—Risks Related to our Business and Operations—If our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein… |
| ALPINEBIO-FINALLY-FOODS-INGREDIENTWERKS-INC-KYOM |
ALPINEBIO-FINALLY-FOODS-INGREDIENTWERKS-INC-KYOM |
62%
|
Item 3. Key Information—D. Risk Factors—Risks Related to our Business and Operations—If our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein… |
| ARGENTINA-MOOLEC-SCIENCE-LIMITED |
ARGENTINA-MOOLEC-SCIENCE-LIMITED |
62%
|
nts S.L. (3) Spain 50 % 50 % Notes:- (1) Moolec Science Limited has a branch office in Argentina, Moolec Science Limited S.E. (2) Acquired pursuant to the ValoraSoy Acquisition, which closed on April… |
| B-BUSINESS-OVERVIEW-SIGNIFICANT-TRANSACTIONS-THE |
B-BUSINESS-OVERVIEW-SIGNIFICANT-TRANSACTIONS-THE |
62%
|
tion/processing, regulatory affairs), synthetic biology and fermentation (R&D, pilot and industrial scale), and sustainable equipment that improves energy use, soil impact and harvest throughput. Cap… |
| BENNETT-AG-RESEARCH-CO |
BENNETT-AG-RESEARCH-CO |
62%
|
Item 3. Key Information—D. Risk Factors—Risks Related to our Business and Operations—If our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein… |
| BIOCERES-GROUP |
BIOCERES-GROUP |
62%
|
anized under relevant headings. These risks are discussed in greater detail below. Risks Relating to Our Business and Operations We are subject to the following risks in respect of our business and o… |
| BIOCERES-GROUP-LIMITED |
BIOCERES-GROUP-LIMITED |
62%
|
MENTS As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023 (Amounts in US$, except otherwise indicated) Considering only this net currency exposure as of June 30, 2025, i… |
| BIOCERES-GROUP-LIMITED-NUTRECON-LLC |
BIOCERES-GROUP-LIMITED-NUTRECON-LLC |
62%
|
2025, 2024 and 2023 (Amounts in US$, except otherwise indicated) 2. ACCOUNTING STANDARDS AND BASIS OF PREPARATION Statement of compliance with IFRS as issued by IASB These consolidated financial stat… |
| BIOCERES-GROUP-NUTRECON-LLC-NORDELIS-UNION-GROUP |
BIOCERES-GROUP-NUTRECON-LLC-NORDELIS-UNION-GROUP |
62%
|
g our inorganic growth strategy, including in respect of integrating the operations of the business we have acquired or expect to acquire in the future. From time to time, we may acquire businesses, … |
| BIOCERES-GROUP-PLC |
BIOCERES-GROUP-PLC |
62%
|
,265 ) 1,055,299 (1,758,564 ) (167 )% Operating profit 19,284,982 98,045,630 (78,760,648 ) (80 )% Financial costs (37,634,153 ) (33,576,632 ) (4,057,521 ) 12 % Other financial results (9,608,981 ) (1… |
| BIOCERES-LLC-BIOCERES-GROUP-LIMITED |
BIOCERES-LLC-BIOCERES-GROUP-LIMITED |
62%
|
,265 ) 1,055,299 (1,758,564 ) (167 )% Operating profit 19,284,982 98,045,630 (78,760,648 ) (80 )% Financial costs (37,634,153 ) (33,576,632 ) (4,057,521 ) 12 % Other financial results (9,608,981 ) (1… |
| CAYMAN-ISLANDS-COMPANY |
CAYMAN-ISLANDS-COMPANY |
62%
|
ks in respect of our intellectual property rights: ● agreements with our collaborators and third parties may not adequately prevent disclosure of trade secrets, know-how and other proprietary informa… |
| COMPANY-BIOCERES-GROUP |
COMPANY-BIOCERES-GROUP |
62%
|
,265 ) 1,055,299 (1,758,564 ) (167 )% Operating profit 19,284,982 98,045,630 (78,760,648 ) (80 )% Financial costs (37,634,153 ) (33,576,632 ) (4,057,521 ) 12 % Other financial results (9,608,981 ) (1… |
| GENTLE-TECHNOLOGIES-CORP |
GENTLE-TECHNOLOGIES-CORP |
62%
|
g our inorganic growth strategy, including in respect of integrating the operations of the business we have acquired or expect to acquire in the future. From time to time, we may acquire businesses, … |
| GIVAUDAN-GROUP |
GIVAUDAN-GROUP |
62%
|
Item 3. Key Information—D. Risk Factors—Risks Related to our Business and Operations—If our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein… |
| IMPOSSIBLE-FOODS-INC |
IMPOSSIBLE-FOODS-INC |
62%
|
Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Note issued to Bioceres Crop Solutions Corp .” We are developing a customer base for our fermentation and molec… |
| INCORPORATION-OWNERSHIP-INTEREST-VOTING-INTEREST |
INCORPORATION-OWNERSHIP-INTEREST-VOTING-INTEREST |
62%
|
ur future products. We are also subject to labor and employment laws, laws governing advertising, privacy laws, safety regulations and other laws. We moved forward in Piggy Sooy™’s regulatory pathway… |
| LEASES-THE-GROUP |
LEASES-THE-GROUP |
62%
|
nd estimates The Group makes certain estimates and assumptions regarding the future. Estimates and judgments are continually evaluated based on historical experience and other factors, including expe… |
| LIGHTJUMP-ACQUISITION-CORPORATION |
LIGHTJUMP-ACQUISITION-CORPORATION |
62%
|
ur future products. We are also subject to labor and employment laws, laws governing advertising, privacy laws, safety regulations and other laws. We moved forward in Piggy Sooy™’s regulatory pathway… |
| LIGHTJUMP-MOOLEC-LIMITED-MOOLEC-ACQUISITION-INC |
LIGHTJUMP-MOOLEC-LIMITED-MOOLEC-ACQUISITION-INC |
62%
|
.com. The SEC also maintains a website at http://www.sec.gov which contains reports and other information regarding registrants that file electronically with the SEC. We do not incorporate the inform… |
| MOOZA-FOODS-NEWMOO-POLOPO-INC |
MOOZA-FOODS-NEWMOO-POLOPO-INC |
62%
|
Item 3. Key Information—D. Risk Factors—Risks Related to our Business and Operations—If our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein… |
| NASDAQ-STOCK-MARKET-LLC |
NASDAQ-STOCK-MARKET-LLC |
62%
|
could subject us to penalties and other adverse consequences. As we expect a substantial portion of our future revenue to come from jurisdictions other than the United States, we face significant ris… |
